Document Detail


Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
MedLine Citation:
PMID:  23110075     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The BRAF oncogene is mutated in 15% of sporadic colorectal cancers. Approximately half of these BRAF mutant cancers demonstrate frequent frameshift mutations termed microsatellite instability (MSI), but are diploid and chromosomally stable. BRAF wild type cancers are typically microsatellite stable (MSS) and instead acquire chromosomal instability (CIN). In these cancers, CIN is associated with a poor outcome. BRAF mutant cancers that are MSS, typically present at an advanced stage and have a particularly poor prognosis. We have previously demonstrated clinical and molecular similarities between MSS cancers with or without a BRAF mutation, and therefore hypothesised that CIN may also be frequent in BRAF mutant/MSS cancers. BRAF mutant/MSS (n = 60), and BRAF wild type/MSS CRCs (n = 90) were investigated for CIN using loss of heterozygosity analysis over twelve loci encompassing chromosomal regions 5q, 8p, 17p and 18q. CIN was frequent in BRAF mutant/MSS cancers (41/57, 72%), which was comparable to the rate found in BRAF wild type/MSS cancers (74/90, 82%). The greatest loss in BRAF mutant/MSS cancers occurred at 8p (26/44, 59%), and the least at 5q (19/49, 39%). CIN in BRAF mutant/MSS cancers correlated with advanced stage (AJCC III/IV: 15/17, 88%; p = 0.02); showed high rates of co-occurrence with the CpG Island Methylator Phenotype (17/23, 74%); and CIN at 18q and 8p associated with worse survival (p = 0.02, p<0.05). This study demonstrates that CIN commonly occurs in advanced BRAF mutant/MSS colorectal cancers where it may contribute to poorer survival, and further highlights molecular similarities occurring between these and BRAF wild type cancers.
Authors:
Catherine E Bond; Aarti Umapathy; Ron L Buttenshaw; Leesa Wockner; Barbara A Leggett; Vicki L J Whitehall
Related Documents :
3678305 - Effect of testicular torsion on the contralateral testis and prevention of this effect ...
21448875 - Proteome and transcriptome profiles of a her2/neu-driven mouse model of breast cancer.
24107445 - Braf v600e is a determinant of sensitivity to proteasome inhibitors.
21498115 - No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.
22315365 - Milk and dairy consumption among men with prostate cancer and risk of metastases and pr...
19861145 - Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-22
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-30     Completed Date:  2013-04-17     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e47483     Citation Subset:  IM    
Affiliation:
Conjoint Gastroenterology Laboratory, The Queensland Institute of Medical Research, Brisbane, Australia. Catherine.Bond@qimr.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Chromosomal Instability / genetics*
Colorectal Neoplasms / genetics*
CpG Islands / genetics
Female
Humans
Loss of Heterozygosity / genetics
Male
Microsatellite Instability
Proto-Oncogene Proteins B-raf / genetics*
Chemical
Reg. No./Substance:
EC 2.7.11.1/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors associated with death in in-hospital pediatric convulsive status epilepticus.
Next Document:  Smooth pursuit and visual occlusion: active inference and oculomotor control in schizophrenia.